Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease

Area of Science:

• Cardiology
• Pulmonology
• Pharmacology

Background:

• Chronic obstructive pulmonary disease (COPD) involves lung, airway, and vascular inflammation.
• Cardiovascular diseases are prevalent in COPD patients.
• The renin-angiotensin system (RAS) plays a role in cardiovascular and lung diseases.

Purpose of the Study:

• To review the role of the RAS in COPD pathogenesis.
• To discuss the potential benefits of ACE inhibition in COPD.
• To explore RAS blockade as a novel therapeutic strategy for COPD.

Main Methods:

• Literature review of studies on RAS, ACE inhibitors, ARBs, and COPD.
• Analysis of evidence from fibrotic lung conditions and pulmonary hypertension.
• Examination of effects on skeletal muscle function and cardiovascular comorbidities.

Main Results:

• The RAS is implicated in the pathological processes of COPD.
• ACE inhibition shows potential for improving skeletal muscle function in COPD.
• RAS blockade may offer therapeutic benefits for cardiovascular comorbidities in COPD.

Conclusions:

• The renin-angiotensin system is a key factor in COPD pathogenesis.
• ACE inhibitors may represent a novel therapeutic approach for COPD patients.
• Further research into RAS blockade for COPD is warranted.